BioSpace News Archive

Gain Therapeutics, Inc. today announced participation in the upcoming Public Ventures Discovery Day on March 19, 2024 at Old Parkland in Dallas, TX.

Scholar Rock today announced that the company granted inducement equity awards on March 11, 2024, covering an aggregate of 201,469 shares of its common stock to six newly hired employees.

Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM) announced that on March 11, 2024, it received two letters from the listing qualifications department staff of The Nasdaq Stock Market.

Azitra, Inc. today reported financial results for the full year ended December 31, 2023, and provided a business update.

Castle Biosciences, Inc. announced new data highlighting the value of its IDgenetix pharmacogenomic test in guiding medication recommendations for patients with mental health conditions who are 65 and older.

CAR T-cell therapy is an innovative form of immunotherapy used in the treatment of cancer.

ProSomnus, Inc. announced it has postponed the release of its 2023 fourth quarter and full year financial results and the related investor conference call.

FDA Advisory Committee Votes in Favor of Bristol Myers Squibb’s and 2seventy bio’s Abecma for Triple-Class Exposed Multiple Myeloma in Earlier Lines of Therapy.

Biofrontera, Inc. today reported financial results for the three and twelve months ended December 31, 2023.

ResMed, the global leader in digital health and cloud-connected medical devices that transform care for people with sleep apnea, COPD, and other chronic diseases, announced the results of its 2024 Global Sleep Survey in conjunction with World Sleep Day, shedding light on the critical sleep challenges faced by people around the world.